Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$45.75 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Enhancing Food Safety:The Role of the Food and Drug Administration Ethical and Scientific Issues in Studying the Safety of Approved Drugs Other Related Titles A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration (2011) Board on Environmental Studies and Toxicology (BEST) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "A Risk-Characterization Framework for Decision-Making at the Food and Drugh Administration." A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration. Washington, DC: The National Academies Press, 2011. Please select a format: Page 1   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. A RISK-CHARACTERIZATION FRAMEWORK FOR DECISION-MAKING AT THE FOOD AND DRUG ADMINISTRATION Page 1 Front Matter (R1-R14) A Risk-Characterization Framework for Decision-Making at the Food and Drugh Administration (1-2) Summary (3-10) 1 Introduction (11-16) 2 A Risk-Characterization Framework (17-45) 3 Case Study of a Mitigation-Selection Decision (46-65) 4 Case Study of a Targeting Decision (66-91) 5 Case Study of a Strategic-Investment Decision (92-110) 6 Case Study of a Targeting Decision That Spans Food and Drug Administration Centers (111-138) 7 Conclusions and Future Directions (139-148) Appendix A: Letter Report on the Development of a Model for Ranking FDA Product Categories on the Basis of Health Risks (149-176) Appendix B: Statement of Task for the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II (177-178) Appendix C: Scenarios Provided by the U.S. Food and Drug Administration to the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II (179-184) Appendix D: Biographic Information on the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II (185-190) Appendix E: Factors Hypothesized as Important in Understanding Risk (191-192)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 1
A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration A RISK-CHARACTERIZATION FRAMEWORK FOR DECISION-MAKING AT THE FOOD AND DRUG ADMINISTRATION

OCR for page 2
A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration This page intentionally left blank.